Mohamed Tawengi, Yazan Al-Dali, Abdelaziz Tawengi, Ibrahim F. Benter, & Saghir Akhtar. (2024). Targeting the epidermal growth factor receptor (EGFR/ErbB) for the potential treatment of renal pathologies. Frontiers Media S.A..
Chicago Style (17th ed.) CitationMohamed Tawengi, Yazan Al-Dali, Abdelaziz Tawengi, Ibrahim F. Benter, and Saghir Akhtar. Targeting the Epidermal Growth Factor Receptor (EGFR/ErbB) for the Potential Treatment of Renal Pathologies. Frontiers Media S.A., 2024.
MLA (9th ed.) CitationMohamed Tawengi, et al. Targeting the Epidermal Growth Factor Receptor (EGFR/ErbB) for the Potential Treatment of Renal Pathologies. Frontiers Media S.A., 2024.
Warning: These citations may not always be 100% accurate.